WS14.01 Elexacaftor/tezacaftor/ivacaftor treatment partially normalizes osteoclasts' bone resorption activity in cystic fibrosis-related bone disease.

Authors :: Sergheraert, J.
Guillaume, C.
Dumortier, C.
Braux, J.
Griffon, M.
Ravoninjatovo, B.
Burgel, P.-R.
Martin, C.
Pierrard, L.
Gangloff, S.C.
Jourdain, M.-L.
Velard, F.
Source :: Journal of Cystic Fibrosis. 2024 Supplement 1, Vol. 23, pS25-S26. 2p.
Publication Year :: 2024

Subjects :: *BONE resorption
*BONE diseases
*OSTEOCLASTS
*THERAPEUTICS
*BRONCHIAL arteries

Full Text Access

Tools